InVivoMAb anti-mouse IFNgamma
BE0312
ApplicationsNeutralisation/Blocking
Product group Antibodies
ReactivityMouse
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse IFNgamma
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDH22
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostHamster
- IsotypeIgG
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Nair S, Poddar S, Shimak RM, et al. Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells. J Virol. 2017,91(22). doi: 10.1128/JVI.01419-17Read this paper
- Noguchi T, Ward JP, Gubin MM, et al. Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape. Cancer Immunol Res. 2017,5(2):106-117. doi: 10.1158/2326-6066.CIR-16-0391Read this paper
- Slaney CY, von Scheidt B, Davenport AJ, et al. Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting. Clin Cancer Res. 2017,23(10):2478-2490. doi: 10.1158/1078-0432.CCR-16-1860Read this paper
- Wu LL, Peng WH, Kuo WT, et al. Commensal bacterial endocytosis in epithelial cells is dependent on myosin light chain kinase-activated brush border fanning by interferon-γ. Am J Pathol. 2014,184(8):2260-74. doi: 10.1016/j.ajpath.2014.05.003Read this paper
- Steed AL, Barton ES, Tibbetts SA, et al. Gamma interferon blocks gammaherpesvirus reactivation from latency. J Virol. 2006,80(1):192-200.Read this paper
- Schreiber RD, Hicks LJ, Celada A, et al. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. J Immunol. 1985,134(3):1609-18.Read this paper
- Leiby DA, Fortier AH, Crawford RM, et al. In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect Immun. 1992,60(1):84-9.Read this paper
